Reply to Author
- PMID: 35993127
- DOI: 10.1093/cid/ciac678
Reply to Author
Conflict of interest statement
Potential conflicts of interest. A. P. L. has received consulting fees from and has contracts with Amplyx Pharmaceuticals and has received consulting fees from AlloVir. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment on
-
BK Polyomavirus Consensus.Clin Infect Dis. 2022 Nov 30;75(11):2046-2047. doi: 10.1093/cid/ciac594. Clin Infect Dis. 2022. PMID: 35856634 No abstract available.